Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the development of estrogen receptor–negative (ERneg) breast cancer, according to recent findings published in Science Advances.

The study, led by Susan Clare, ‘90 MD, ‘88 Ph.D., research associate professor of Surgery, and Seema Khan, MD, the Bluhm Family Professor of Cancer, has the potential to inform new targeted preventives and therapeutics for patients who currently have limited treatment options.

Mariana Bustamante Eduardo, Ph.D., a postdoctoral fellow in the Khan/Clare laboratory, was lead author of the study.